GH Research

About:

GH Research is a biopharmaceutical company developing novel therapies for the management of mental illness.

Top Investors: RA Capital Management, Deerfield, Cormorant Asset Management, Biotechnology Value Fund, RTW Investments

Description:

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders. GH Research PLC's initial focus is on developing its novel and proprietary 5-MeO-DMT therapies for the treatment of patients with Treatment-Resistant Depression.

Total Funding Amount:

$125M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Dublin, Dublin, Ireland

Founded Date:

2018-01-01

Contact Email:

info(AT)ghres.com

Founders:

Florian Schonharting, Theis Terwey

Number of Employees:

11-50

Last Funding Date:

2021-04-12

IPO Status:

Public

Industries: